摘要 |
The present invention of compounds of formula (I) a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, R<SUP>1 </SUP>and R<SUP>2 </SUP>taken together form a bivalent radical of formula wherein in said bivalent radicals one or two hydrogen atoms may be substituted with C<SUB>1-6</SUB>alkyl; R<SUP>3 </SUP>is hydrogen or halo; R<SUP>4 </SUP>is hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>5 </SUP>is hydrogen or C<SUB>1-6</SUB>alkyl; L is C<SUB>3-6</SUB>cycloalkyl, C<SUB>5-6</SUB>cycloalkanone, C<SUB>2-6</SUB>alkenyl, or L is a radical of formula -Alk-R<SUP>6</SUP>-, Alk-X-R<SUP>7</SUP>, -Alk-Y-C(-O)-R<SUP>9</SUP>, or -Alk-Y-C(-O)-NR<SUP>11</SUP>R<SUP>12 </SUP>wherein each Alk is C<SUB>1-12</SUB>alkanediyl; and R<SUP>6 </SUP>is hydrogen, cyano, C<SUB>1-6</SUB>alkylsulfonylamino, C<SUB>3-6</SUB>cycloalkyl, C<SUB>5-6</SUB>cycloalkanone, or a heterocyclic ringsystem; R<SUP>7 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, hydroxyC<SUB>1-6</SUB>alkyl, C<SUB>3-6</SUB>cycloalkyl, or a heterocyclic ringsystem; X is O, S, SO<SUB>2 </SUB>or NR<SUP>8</SUP>; said R<SUP>8 </SUP>being hydrogen or C<SUB>1-6</SUB>alkyl; R<SUP>9 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, C<SUB>3-6</SUB>cycloalkyl, C<SUB>1-6</SUB>alkyloxy or hydroxy; Y is NR<SUP>10 </SUP>or a direct bond; said R<SUP>10 </SUP>being hydrogen, or C<SUB>1-6</SUB>alkyl; R<SUP>11 </SUP>and R<SUP>12 </SUP>each independently are hydrogen, C<SUB>1-6</SUB>alkyl, C<SUB>3-6</SUB>cycloalkyl, or R<SUP>11</SUP>and R<SUP>12 </SUP>combined with the nitrogen atom may form an optionally substituted pyrrolidinyl, piperidinyl, piperazinyl or 4-morpholinyl ring. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for treating conditions which are related to impairment of gastric emptying.
|